Le fermenteur à bioréaction

(nanomedicinecenter) - Large-cap biotech stocks are safe to invest in, says a report by Barron’s. They aren’t risky or expensive anymore, as many claim, despite their reputation. Of course, biotech stocks have fallen and aren’t near their highs posted in August, but they’re still “in a good shape” when compared to other industry branches (the AMEX Biotechnology Index remains 36% off its record in August).

Barron’s asked a number of experts to talk on the issue. “The big players in the biotech industry will grow despite what happens in the economy.” says Evan McCulloh, Franklin Biotechnology Discover Fund. “When the value of other stocks is falling, there is a positive vibe around big biotech stocks.”

.....

Lire la suite de l'article sur nanomedcine